Combinatorial Chemistry & High Throughput Screening
Title:Editorial: Breaking the Discovery Impasse (Part 2): Deep Learning New Tricks from Old Data
Volume: 21 Issue: 4
Author(s): Gerald H. Lushington
Affiliation:
Export Options
About this article
Cite this article as:
Lushington H. Gerald, Editorial: Breaking the Discovery Impasse (Part 2): Deep Learning New Tricks from Old Data, Combinatorial Chemistry & High Throughput Screening 2018; 21 (4) . https://dx.doi.org/10.2174/138620732104180525085003
DOI https://dx.doi.org/10.2174/138620732104180525085003 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
28
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antimicrobial Potential of Benzimidazole Derived Molecules
Mini-Reviews in Medicinal Chemistry Reactive Oxygen Species, Inflammation, and Lung Diseases
Current Pharmaceutical Design COVID-19: The Significance of Platelets, Mitochondria, Vitamin D, Serotonin and the Gut Microbiota
Current Medicinal Chemistry Chemometric Studies on Potential Larvicidal Compounds Against Aedes Aegypti
Medicinal Chemistry Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein 1: Recent Developments Concerning Substrates and Inhibitors of a Promising Therapeutic Target
Current Medicinal Chemistry Novel Corona-Virus Disease 2019 (COVID-19): A Perilous Life- Threatening Epidemic
Coronaviruses Recent Advances in the Synthesis of Biologically Active Cinnoline, Phthalazine and Quinoxaline Derivatives
Current Organic Chemistry Liver Injury in COVID-19: A Direct Hit or Collateral Damage?
Infectious Disorders - Drug Targets Development of Effective Therapeutics Targeting the GABAA Receptor: Naturally Occurring Alternatives
Current Pharmaceutical Design Computational Prediction of Properties and Analysis of Molecular Phylogenetics of Polyketide Synthases in Three Species of Actinomycetes
Medicinal Chemistry Docking: Successes and Challenges
Current Pharmaceutical Design Discovery of Novel Dinitrobenzotrifluoride Containing o-Hydroxybenzylamine Derivatives as Potential Antibacterial Agents
Medicinal Chemistry Recent Development of Anticancer Therapeutics Targeting Akt
Recent Patents on Anti-Cancer Drug Discovery Development of Neurochemical Normalization (“Agonist Substitution”) Therapeutics for Stimulant Abuse: Focus on the Dopamine Uptake Inhibitor, GBR12909
Current Medicinal Chemistry - Central Nervous System Agents Cyclic Opioid Peptides
Current Medicinal Chemistry Can we Succeed in the Fight Against SARS-CoV-2 with its Emerging New Variants?
Current Pharmaceutical Design Recent Developments of Coumarin Hybrids as Anti-fungal Agents
Current Topics in Medicinal Chemistry Histone Deacetylase Inhibitors: The Abbott Experience
Current Medicinal Chemistry Phospho-eIF4E: A New Target for Acute Myeloid Leukemia
Current Protein & Peptide Science Pyrrolo[3,4-c]Quinoline-1,3-Diones as Potent Caspase-3 Inhibitors: Synthesis and SAR of 8-Sulfamoyl-1,3-Dioxo-2,3-Dihydro-1H-Pyrrolo[3,4- c]Quinolines
Letters in Drug Design & Discovery